| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a74390f853459a9050079b249ffe824 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 |
| filingDate |
1980-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce95f23529b5d57203c7dfc48030ed37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c97f41a3c67db3f6b18362ea82beebc |
| publicationDate |
1982-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0047339-A1 |
| titleOfInvention |
Drug for the local treatment of glaucoma |
| abstract |
Medicines for use in the eye in the form of eye drops, eye ointment, eye gel, eye insert or lyophilisate for the preparation of eye drops, which besides dipivefrin in therapeutically usual dosages (0.05-0.2%) contains guanethidine as a second active ingredient in concentrations that are well below the usual dosage is only 0.05 to 1.0%. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5079253-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8807380-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2571962-A1 |
| priorityDate |
1980-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |